Regulatory T cells in HIV infection: Pathogenic or protective participants in the immune response?

AIDS

Volumn 22, Issue 6, 2008, Pages 671-683

  De St Groth, Barbara Fazekas ^a,c   Landay, Alan L ^b  

^a University of Sydney   (Australia)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c CENTENARY INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL DEXTRO TRYPTOPHAN; ANTIRETROVIRUS AGENT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3 DIOXYGENASE INHIBITOR; INTERLEUKIN 2; INTERLEUKIN 7; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

ADRENAL INSUFFICIENCY; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELL COUNT; CELL FUNCTION; CELL SELECTION; CELL SPECIFICITY; CELLULAR IMMUNITY; CLINICAL TRIAL; COLITIS; CYTOKINE RELEASE; DRUG MEGADOSE; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOPHYSITIS; IMMUNE RESPONSE; LEISHMANIA; LOW DRUG DOSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE SUBPOPULATION; VIRUS ENTRY; VIRUS REPLICATION; CD4+ CD25+ T LYMPHOCYTE; CELL PROLIFERATION; FEEDBACK SYSTEM; GENE EXPRESSION; HEPATITIS C; IMMUNOREGULATION; IN VITRO STUDY; INFLAMMATION; SUPPRESSOR CELL;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; APOPTOSIS REGULATORY PROTEINS; FEEDBACK, BIOCHEMICAL; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-2; MICE; MODELS, ANIMAL; RESEARCH DESIGN; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 41349101159     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3282f466da     Document Type: Review

References (146)

1. Gershon RK, Kondo K. Infectious immunological tolerance. Immunology 1971; 21:903-914.
2. + suppressor cell and its mechanisms of action. J Exp Med 1990; 171:141-157.
3. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25); breakdown of a single mechanism. J Immunol 1995; 155:1151-1164.
4. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188: 287-296.
5. high regulatory cells in human peripheral blood. J Immunol 2001; 167:1245-1253.
6. + suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2:389-400.
7. + Tregs and immune control. J Clin Invest 2004; 114:1209-1217.
8. Bluestone JA. Regulatory T-cell therapy: is it ready for the clinic? Nat Rev 2005; 5:343-349.
9. Shevach EM. From vanilla to 28 flavors: Multiple varieties of regulatory T cells. Immunity 2006; 25:195-201.
10. Boasso A, Vaccari M, Nilsson J, Shearer GM, Andersson J, Cecchinato V, et al. Do regulatory T-cells play a role in AIDS pathogenesis. AIDS Rev 2006; 8:141-147.
11. Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, Bowcock AM. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2000; 106:R75-R81.
12. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001; 27:18-20.
13. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27:20-21.
14. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001; 27:68-73.
15. Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005; 6: 331-337.
16. + regulatory T cells at the single-cell level. Eur J Immunol 2005; 35:1681-1691.
17. + regulatory T cells in adult life. Blood 2006; 107:2830-2838.
18. Valmori D, Merlo A, Souleimania N, Hesdorffer C, Ayyoub M. A peripheral circulating compartment of natural naive CD4 Tregs. J Clin Invest 2005; 115:1953-1962.
19. Fritzsching B, Oberle N, Pauly E, Geffers R, Buer J, Poschl J, et al. Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. Blood 2006; 108:3371-3378.
20. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, et al. Expression of IL-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203:1693-1700.
21. + T reg cells. J Exp Med 2006; 203:1701-1711.
22. Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. J Exp Med 1985; 161:72-87.
23. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005; 22:329-341.
24. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-1061.
25. + regulatory cells that control intestinal inflammation. J Exp Med 2000; 192:295-302.
26. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192:303-309.
27. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002; 16:311-323.
28. + regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002; 3:135-142.
29. + regulatory T cells in the steady state. J Exp Med 2003; 198:737-746.
30. + T cells. J Leukoc Biol 2004; 75:785-791.
31. + T cells induce or protect from chronic intestinal inflammation in C.B17 scid mice. Int Immunol 1993; 5:1461-1471.
32. + suppressor T cells in vivo. Nat Immunol 2002; 3:33-41.
33. - regulatory T cells. Proc Natl Acad Sci U S A 2002; 99:13031-13036.
34. + T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001; 193:1285-1294.
35. - T suppressor cells. Hum Immunol 2004; 65:1297-1306.
36. Ruprecht CR, Gattorno M, Ferlito F, Gregorio A, Martini A, Lanzavecchia A, Sallusto F. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med 2005; 201:1793-1803.
37. Ma BY, Mikolajczak SA, Danesh A, Hosiawa KA, Cameron CM, Takaori-Kondo A, et al. The expression and the regulatory role of OX40 and 4-1BB heterodimer in activated human T cells. Blood 2005; 106:2002-2010.
38. Baecher-Allan C, Wolf E, Hafler DA. MHC class II expression identifies functionally distinct human regulatory T cells. J Immunol 2006; 176:4622-4631.
39. + regulatory T cell activity in both humans and mice. J Immunol 2004; 172:834-842.
40. - T cells. J Clin Invest 2003; 112:1437-1443.
41. + T regulatory cells in humans. Hum Immunol 2005; 66:13-20.
42. Allan SE, Passerini L, Bacchetta R, Crellin N, Dai M, Orban PC, et al. The role of 2 FOXP3 isoforms in the generation of human CD4 Tregs. J Clin Invest 2005; 115:3276-3284.
43. + T cells. Eur J Immunol 2007; 37:129-138.
44. Gavin MA, Torgerson TR, Houston E, DeRoos P, Ho WY, Stray-Pedersen A, et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A 2006; 103:6659-6664.
45. + T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999; 163:5211-5218.
46. + regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420:502-507.
47. + regulatory T cells. J Exp Med 2005; 201:1061-1067.
48. Li MO, Sanjabi S, Flavell RA. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T-cell-dependent and-independent mechanisms. Immunity 2006; 25:455-471.
49. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190:995-1003.
50. + regulatory T cells. Int Immunol 2004; 16:249-256.
51. + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 2005; 174:1783-1786.
52. Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, Bianchi R, et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 2003; 4:1206-1212.
53. Munn DH, Mellor AL. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 2007; 117:1147-1154.
54. + regulatory T cells. Immunol Rev 2006; 212: 60-73.
55. Tang Q, Adams JY, Tooley AJ, Bi M, Fife BT, Serra P, et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 2006; 7:83-92.
56. + regulatory T cell function. Eur J Immunol 2004; 34:2996-3005.
57. + regulatory T cells is not essential for suppression of intestinal inflammation. Eur J Immunol 2005; 35:2886-2895.
58. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 2000; 30:1538-1543.
59. + T cells restrain the maturation and antigen-presenting function of dendritic cells. J Immunol 2004; 172:4676-4680.
60. + regulatory T cells. Hum Immunol 2005; 66:222-230.
61. Mellor AL, Baban B, Chandler P, Marshall B, Jhaver K, Hansen A, et al. Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J Immunol 2003; 171:1652-1655.
62. + regulatory T cells. Nat Immunol 2003; 4:330-336.
63. Apostolou I, von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J Exp Med 2004; 199:1401-1408.
64. + regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J Immunol 2004; 172:6003-6010.
65. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198:1875-1886.
66. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, Cheroutre H. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007; 317:256-260.
67. + regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 2007; 204:1757-1764.
68. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR, Belkaid Y. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007; 204:1775-1785.
69. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 2007; 204:1765-1774.
70. + natural regulatory T cells are specific for microbial antigens. J Exp Med 2006; 203:777-788.
71. + regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versusleukemia. J Clin Invest 2003; 112:1688-1696.
72. Li S, Jones KL, Woollard DJ, Dromey J, Paukovics G, Plebanski M, Gowans EJ. Defining target antigens for CD25+FOXP3+IFN-gamma- regulatory T cells in chronic hepatitis C virus infection. Immunol Cell Biol 2007; In press.
73. + regulatory T cells from human peripheral blood. J Immunol 2001; 166:7282-7289.
74. + regulatory T cells by 1,25-dihydroxyvitamin D3. Blood 2005; 106:3490-3497.
75. + T cells. J Immunol 2005; 175:1483-1490.
76. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75:253-261.
77. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW. Interleukin-2 receptor a chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995; 3:521-530.
78. Suzuki H, Kundig TM, Furlonger C, Wakeham A, Timms E, Matsuyama T, et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 1995; 268:1472-1476.
79. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005; 6:1142-1151.
80. Nakajima H, Liu XW, Wynshaw-Boris A, Rosenthal LA, Imada K, Finbloom DS, et al. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction. Immunity 1997; 7:691-701.
81. + T cell suppressor function. J Immunol 2004; 172:6519-6523.
82. + regulatory T cell function. Eur J Immunol 2004; 34:2480-2488.
83. +regulatory T cells. Nat Med 2005; 11:1238-1243.
84. + T cells expressing foxP3 in IL-2-treated HIV-infected patients. J Clin Invest 2005; 115:1839-1847.
85. + regulatory T cells in cancer patients. Blood 2006; 107:2409-2414.
86. Shah MH, Freud AG, Benson DM Jr, Ferkitich AK, Dezube BJ, Bernstein ZP, Caligiuri MA. A phase I study of ultra low dose interleukin-2 and stem cell factor in patients with HIV infection or HIV and cancer. Clin Cancer Res 2006; 12:3993-3996.
87. + regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 2006; 108:1571-1579.
88. 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 1993; 90:770-774.
89. high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity. Inflamm Bowel Dis 2006; 12:447-456.
90. + regulatory T cells are numerically deficient in acute and chronic GvHD. Blood 2006; 107:1717- 1723.
91. Bachmann MF, Kohler G, Ecabert B, Mak TW, Kopf M. Lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J Immunol 1999; 163:1128-1131.
92. Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, Vacca C, et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol 2006; 176:6752-6761.
93. Phan GQ, Yang JC, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci U S A 2003; 100:8372-8377.
94. Maker AV, Attia P, Rosenberg SA. Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade. J Immunol 2005; 175:7746-7754.
95. Weber J. Review: anti-CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events. The Oncologist 2007; 12:864-872.
96. + regulatory cells. J Immunol 2006; 176:3321-3329.
97. + T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J Immunol 2004; 172:4100-4110.
98. + T cells. Blood 2005; 105:1574-1581.
99. + T regulatory cells. Blood 2007; 109:2871-2877.
100. Okazaki T, Honjo T. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol 2006; 27:195-201.
101. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 2007; 8:239-245.
102. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443:350-354.
103. + T cell survival in HIV infection. J Exp Med 2006; 203:2281-2292.
104. Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, Bessette B, et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 2006; 12:1198-1202.
105. + resting regulatory T cells from activated T cells. J Immunol 2006; 176:2808-2816.
106. + regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004; 40:1062-1071.
107. + T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels. Clin Exp Immunol 2006; 144:188-196.
108. + T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C. Blood 2006; 107:4424-4432.
109. + T helper cell depletion occurs. J Clin Invest 1988; 82:1908-1914.
110. Oswald-Richter K, Grill SM, Shariat N, Leelawong M, Sundrud MS, Haas DW, Unutmaz D. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol 2004; 2:e198.
111. + HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 2004; 200:331-343.
112. + regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004; 104:3249-3256.
113. Eggena MP, Barugahare B, Jones N, Okello M, Mutalya S, Kityo C, et al. Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 2005; 174: 4407-4414.
114. Andersson J, Boasso A, Nilsson J, Zhang R, Shire NJ, Lindback S, et al. The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol 2005; 174:3143-3147.
115. + regulatory T cells to immune status in HIV-infected patients. AIDS 2005; 19:879-886.
116. + lymphocytes from HIV-positive patients. J Acquir Immune Defic Syndr 2005; 39:381-385.
117. Krathwohl MD, Schacker TW, Anderson JL. Abnormal presence of semimature dendritic cells that induce regulatory T cells in HIV-infected subjects. J Infect Dis 2006; 193:494-504.
118. Estes JD, Li Q, Reynolds MR, Wietgrefe S, Duan L, Schacker T, et al. Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J Infect Dis 2006; 193:703-712.
119. + regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 2006; 108:3072-3078.
120. + regulatory T cells in antiretroviral-naive HIV patients. AIDS 2006; 20:1669-1671.
121. Lim AY, Price P, Beilharz MW, French MA. Cell surface markers of regulatory T cells are not associated with increased forkhead box p3 expression in blood CD4+ T cells from HIV-infected patients responding to antiretroviral therapy. Immunol Cell Biol 2006; 84:530-536.
122. Nilsson J, Boasso A, Velilla PA, Zhang R, Vaccari M, Franchini G, et al. HIV-1 driven regulatory T cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 2006; 108:3808-3817.
123. + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-759.
124. + T cell depletion and viral replication in SIV infection. Science 1998; 280:427-431.
125. + T cells and over-expression of CTLA-4 are linked to loss of antigenspecific CD4 T cells during primary HIV-1 infection. J Virol 2006; 80:10162-10172.
126. Grant C, Oh U, Fugo K, Takenouchi N, Griffith C, Yao K, et al. Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathways. PLoS Pathog 2006; 2:e33.
127. + T cells by dendritic cells in HIV-infected persons with amebic liver abscess. J Acquir Immune Defic Syndr 2007; 44:6-13.
128. + regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 2004; 78:2454-2459.
129. Jesser RD, Li S, Weinberg A. Regulatory T cells generated during cytomegalovirus in vitro stimulation of mononuclear cells from HIV-infected individuals on HAART correlate with decreased lymphocyte proliferation. Virology 2006; 352:408-417.
130. Legrand FA, Nixon DF, Loo CP, Ono E, Chapman JM, Miyamoto M, et al. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLoS ONE 2006; 1:e102.
131. + regulatory T cells from HIV-infected individuals. Proc Natl Acad Sci U S A 2007; 104:3390-3395.
132. + T cells in vitro. AIDS Res Hum Retroviruses 2007; 23:438-450.
133. + T cells. J Immunol 2007; 178:3265-3271.
134. Baker CA, Clark R, Ventura F, Jones NG, Guzman D, Bangsberg DR, Cao H. Peripheral CD4 loss of regulatory T cells is associated with persistent viraemia in chronic HIV infection. Clin Exp Immunol 2007; 147:533-539.
135. Kornfeld C, Ploquin MJ, Pandrea I, Faye A, Onanga R, Apetrei C, et al. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest 2005; 115:1082-1091.
136. Estes JD, Wietgrefe S, Schacker T, Southern P, Beilman G, Reilly C, et al. Simian immunodeficiency virus-induced lymphatic tissue fibrosis is mediated by transforming growth factor beta 1-positive regulatory T cells and begins in early infection. J Infect Dis 2007; 195:551-561.
137. Hryniewicz A, Boasso A, Edghill-Smith Y, Vaccari M, Fuchs D, Venzon D, et al. CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. Blood 2006; 108:3834-3842.
138. Potula R, Poluektova L, Knipe B, Chrastil J, Heilman D, Dou H, et al. Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis. Blood 2005; 106: 2382-2390.
139. Dannull J, Su Z, Rizzieri D, Yang BK, Coleman D, Yancey D, et al. Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest 2005; 115:3623-3633.
140. Kocak E, Lute K, Chang X, May KF Jr, Exten KR, Zhang H, et al. Combination therapy with anti-CTL antigen-4 and anti4-1BB antibodies enhances cancer immunity and reduces autoimmunity. Cancer Res 2006; 66:7276-7284.
141. Colle JH, Moreau JL, Fontanet A, Lambotte O, Joussemet M, Jacod S, et al. Regulatory dysfunction of the interleukin-7 receptor in CD4 and CD8 lymphocytes from HIV-infected patients-effects of antiretroviral therapy. J Acquir Immune Defic Syndr 2006; 42:277-285.
142. Napolitano LA, Grant RM, Deeks SG, Schmidt D, De Rosa SC, Herzenberg LA, et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 2001; 7:73-79.
143. Smithgall MD, Wong JG, Critchett KE, Haffar OK. IL-7 up-regulates HIV-1 replication in naturally infected peripheral blood mononuclear cells. J Immunol 1996; 156:2324-2330.
144. + thymocytes: a critical role for tumor necrosis factor and interleukin-7. J Virol 1999; 73:7533-7542.
145. + T-regulatory cells. J Immunother 2006; 29:313-319.
146. Beq S, Nugeyre MT, Ho Tsong Fang R, Gautier D, Legrand R, Schmitt N, et al. IL-7 induces immunological improvement in SIV-infected rhesus macaques under antiviral therapy. J Immunol 2006; 176:914-922.